2025 Menopause Medicine Exam Prep:
Clinical Scenarios, MCQs, and Rationales
Climacteric phase refers to:
a) The time from puberty to menopause
b) The period of endocrinologic, somatic, and psychological changes around menopause
c) The first 5 years after menopause
d) Only the cessation of menstruation
Rationale: The climacteric phase includes physiological and hormonal changes around
menopause. It is not limited to the final menstrual period alone.
Primary ovarian insufficiency (POI) is defined as:
a) Menopause after age 55
b) Menopause occurring before age 40
c) Hot flashes beginning before age 45
d) Elevated estradiol before menopause
Rationale: POI is menopause before age 40. Menopause between 40–45 is considered early
menopause.
Early menopause transition (Stage -2) is defined by:
a) 12 months of amenorrhea
b) A persistent ≥7-day difference in consecutive menstrual cycle lengths
c) FSH >25 IU/L
d) Absence of ovulation for 6 months
Rationale: Stage -2 is recognized by menstrual variability of ≥7 days. Amenorrhea of 60+ days
defines Stage -1.
Late menopause transition (Stage -1) is characterized by:
a) Mild hot flashes only
b) 60 or more consecutive days of amenorrhea
c) Normal FSH levels
d) Return of regular ovulation
,Rationale: Stage -1 includes prolonged amenorrhea (>60 days). FSH rises significantly at this
stage.
Which hormone is the most reliable marker of ovarian reserve and menopause transition?
a) FSH
b) Estradiol
c) Anti-Müllerian hormone (AMH)
d) Progesterone
Rationale: AMH reflects remaining follicle pool and declines early. FSH varies by cycle, making it
less reliable.
Why is checking FSH alone not a reliable test for diagnosing menopause?
a) It is expensive
b) Levels fluctuate depending on cycle day and can appear normal
c) FSH always remains low in menopause
d) It cannot be measured in serum
Rationale: FSH is variable in perimenopause; normal or low levels do not exclude menopause
transition.
In menopause, which tissues contain estrogen receptors that are affected by declining
estrogen?
a) Brain and pancreas
b) Vagina, vulva, urethra, and bladder trigone
c) Liver and kidneys
d) Lungs and spleen
Rationale: Estrogen receptors are prominent in lower genitourinary tract tissues and decrease
with menopause.
Typical vaginal changes during menopause include:
a) Increased rugae and thickened epithelium
b) Increased lubrication
c) Thinning, loss of elasticity, and reduced rugae
d) Darkened pigmentation of vaginal tissue
Rationale: Estrogen loss leads to atrophy, thinning, pale mucosa, and fewer rugae.
,Which type of urinary incontinence improves with topical vaginal estrogen?
a) Overflow incontinence
b) Urge or mixed incontinence (urethral atrophy-related)
c) Stress incontinence exclusively
d) Neurogenic bladder
Rationale: Topical estrogen mainly helps urgency/mixed incontinence by improving urethral
mucosal health. It does not effectively treat stress incontinence alone.
Which ethnic group typically has the lowest estradiol levels during menopause transition?
a) Black women
b) Hispanic women
c) White women
d) Chinese and Japanese women
Rationale: Asian women, particularly Chinese and Japanese, have lower estradiol levels than
other groups.
What hormones continue to be secreted by the postmenopausal ovary?
a) Progesterone and estradiol
b) Estrogen only
c) Testosterone and androstenedione
d) DHEA and cortisol
Rationale: Postmenopausal ovaries still produce androgens (testosterone, androstenedione),
not progesterone or estradiol.
Obese women during menopause are more likely to have:
a) Lower estrone levels
b) Higher estradiol/estrone levels due to peripheral aromatization
c) Less risk of endometrial hyperplasia
d) Faster bone loss
Rationale: Adipose tissue converts androgens to estrone, increasing systemic estrogen and
increasing endometrial cancer risk.
Follicular-phase decrease in inhibin B during perimenopause leads to:
a) Increased LH only
, b) Decreased FSH
c) Increased FSH due to reduced negative feedback on the pituitary
d) Increased progesterone production
Rationale: Inhibin B normally suppresses FSH. When inhibin B drops, FSH levels rise to stimulate
follicular growth.
Which of the following is NOT a diagnostic feature of primary ovarian insufficiency (POI)?
a) Amenorrhea for ≥4 months
b) FSH levels consistently below 10 IU/L
c) Two elevated FSH readings (>40 IU/L) taken 4–6 weeks apart
d) Occurs before age 40
Rationale: POI is characterized by amenorrhea and high FSH levels (>40 IU/L), not low FSH.
What physiological change explains hot flashes during menopause?
a) Decreased thyroid hormone
b) Estrogen withdrawal causing hypothalamic thermoregulatory instability
c) Increased serotonin production
d) Elevated cortisol
Rationale: Low estrogen narrows the thermoneutral zone in the hypothalamus, triggering
vasodilation and sweating (hot flashes).
Estrone (E1) becomes the predominant estrogen in postmenopausal women because:
a) Ovaries increase estradiol production
b) Peripheral aromatization of androstenedione in adipose tissue
c) High progesterone stimulates estrone
d) Adrenal glands secrete estrone directly
Rationale: After menopause, estrone is mainly produced in fat tissue by converting androgens
to estrogen.
Which lab finding is most consistent with late perimenopause?
a) Normal FSH and AMH
b) FSH >25 IU/L and AMH undetectable
c) High progesterone
Clinical Scenarios, MCQs, and Rationales
Climacteric phase refers to:
a) The time from puberty to menopause
b) The period of endocrinologic, somatic, and psychological changes around menopause
c) The first 5 years after menopause
d) Only the cessation of menstruation
Rationale: The climacteric phase includes physiological and hormonal changes around
menopause. It is not limited to the final menstrual period alone.
Primary ovarian insufficiency (POI) is defined as:
a) Menopause after age 55
b) Menopause occurring before age 40
c) Hot flashes beginning before age 45
d) Elevated estradiol before menopause
Rationale: POI is menopause before age 40. Menopause between 40–45 is considered early
menopause.
Early menopause transition (Stage -2) is defined by:
a) 12 months of amenorrhea
b) A persistent ≥7-day difference in consecutive menstrual cycle lengths
c) FSH >25 IU/L
d) Absence of ovulation for 6 months
Rationale: Stage -2 is recognized by menstrual variability of ≥7 days. Amenorrhea of 60+ days
defines Stage -1.
Late menopause transition (Stage -1) is characterized by:
a) Mild hot flashes only
b) 60 or more consecutive days of amenorrhea
c) Normal FSH levels
d) Return of regular ovulation
,Rationale: Stage -1 includes prolonged amenorrhea (>60 days). FSH rises significantly at this
stage.
Which hormone is the most reliable marker of ovarian reserve and menopause transition?
a) FSH
b) Estradiol
c) Anti-Müllerian hormone (AMH)
d) Progesterone
Rationale: AMH reflects remaining follicle pool and declines early. FSH varies by cycle, making it
less reliable.
Why is checking FSH alone not a reliable test for diagnosing menopause?
a) It is expensive
b) Levels fluctuate depending on cycle day and can appear normal
c) FSH always remains low in menopause
d) It cannot be measured in serum
Rationale: FSH is variable in perimenopause; normal or low levels do not exclude menopause
transition.
In menopause, which tissues contain estrogen receptors that are affected by declining
estrogen?
a) Brain and pancreas
b) Vagina, vulva, urethra, and bladder trigone
c) Liver and kidneys
d) Lungs and spleen
Rationale: Estrogen receptors are prominent in lower genitourinary tract tissues and decrease
with menopause.
Typical vaginal changes during menopause include:
a) Increased rugae and thickened epithelium
b) Increased lubrication
c) Thinning, loss of elasticity, and reduced rugae
d) Darkened pigmentation of vaginal tissue
Rationale: Estrogen loss leads to atrophy, thinning, pale mucosa, and fewer rugae.
,Which type of urinary incontinence improves with topical vaginal estrogen?
a) Overflow incontinence
b) Urge or mixed incontinence (urethral atrophy-related)
c) Stress incontinence exclusively
d) Neurogenic bladder
Rationale: Topical estrogen mainly helps urgency/mixed incontinence by improving urethral
mucosal health. It does not effectively treat stress incontinence alone.
Which ethnic group typically has the lowest estradiol levels during menopause transition?
a) Black women
b) Hispanic women
c) White women
d) Chinese and Japanese women
Rationale: Asian women, particularly Chinese and Japanese, have lower estradiol levels than
other groups.
What hormones continue to be secreted by the postmenopausal ovary?
a) Progesterone and estradiol
b) Estrogen only
c) Testosterone and androstenedione
d) DHEA and cortisol
Rationale: Postmenopausal ovaries still produce androgens (testosterone, androstenedione),
not progesterone or estradiol.
Obese women during menopause are more likely to have:
a) Lower estrone levels
b) Higher estradiol/estrone levels due to peripheral aromatization
c) Less risk of endometrial hyperplasia
d) Faster bone loss
Rationale: Adipose tissue converts androgens to estrone, increasing systemic estrogen and
increasing endometrial cancer risk.
Follicular-phase decrease in inhibin B during perimenopause leads to:
a) Increased LH only
, b) Decreased FSH
c) Increased FSH due to reduced negative feedback on the pituitary
d) Increased progesterone production
Rationale: Inhibin B normally suppresses FSH. When inhibin B drops, FSH levels rise to stimulate
follicular growth.
Which of the following is NOT a diagnostic feature of primary ovarian insufficiency (POI)?
a) Amenorrhea for ≥4 months
b) FSH levels consistently below 10 IU/L
c) Two elevated FSH readings (>40 IU/L) taken 4–6 weeks apart
d) Occurs before age 40
Rationale: POI is characterized by amenorrhea and high FSH levels (>40 IU/L), not low FSH.
What physiological change explains hot flashes during menopause?
a) Decreased thyroid hormone
b) Estrogen withdrawal causing hypothalamic thermoregulatory instability
c) Increased serotonin production
d) Elevated cortisol
Rationale: Low estrogen narrows the thermoneutral zone in the hypothalamus, triggering
vasodilation and sweating (hot flashes).
Estrone (E1) becomes the predominant estrogen in postmenopausal women because:
a) Ovaries increase estradiol production
b) Peripheral aromatization of androstenedione in adipose tissue
c) High progesterone stimulates estrone
d) Adrenal glands secrete estrone directly
Rationale: After menopause, estrone is mainly produced in fat tissue by converting androgens
to estrogen.
Which lab finding is most consistent with late perimenopause?
a) Normal FSH and AMH
b) FSH >25 IU/L and AMH undetectable
c) High progesterone
